Cardiovascular Protection by Metformin: Latest Advances in Basic and Clinical Research.

Li, Jason Z; Li, Y Robert

Li, Jason Z; Li, Y Robert.

Affiliation

Li JZ; MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
Li YR; Department of Pharmacology, Campbell University Jerry Wallace School of Osteopathic Medicine, Buies Creek, North Carolina, USA.

Cardiology ; 148(4): 374-384, 2023.

Article in En | MEDLINE | ID: mdl-37307806

Subject(s)

Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Heart Failure; Metformin; Humans; Metformin/therapeutic use; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Heart Failure/drug therapy; Atherosclerosis/drug therapy; Glucose; Cardiovascular Diseases/drug therapy; Cardiovascular Diseases/prevention & control

Key words

Atherosclerosis; Cardiovascular protection; Heart failure; Metformin; Myocardial injury

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Atherosclerosis / Heart Failure / Metformin Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Cardiology Year: 2023 Document type: Article Affiliation country: United States Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google